Re-escalation to 2.4 mg once weekly may be considered if the lower dose is tolerated
It strategically targets various organs, including the pancreas for insulin secretion, the GI tract for hunger management, and the brain for appetite control, thus fostering a conducive environment for weight loss
To view a copy of this licence, visit About this article Cite this article Windram, M., Lovelock, D.F., Carew, J.M
Yes, but you should consult your healthcare provider
For example, administration of 2.4 mg/week of semaglutide (instead of 1 mg used in diabetics) for 68 weeks leads to average losses of 15% of initial body weight, approximately double that in type 2 diabetics (Figure 5A)